DRTECH Corporation
DRTECH Corporation develops and sells flat-panel X-ray detectors for digital radiography in South Korea and internationally. Its products include detectors for general radiography, mammography, dynamic, dental, veterinary, and industrial applications; imaging solutions, including specialized UI software, dual energy x-ray imaging, AI imaging processing, advanced image reconstruction technology, a… Read more
DRTECH Corporation (214680) - Net Assets
Latest net assets as of September 2025: ₩76.77 Billion KRW
Based on the latest financial reports, DRTECH Corporation (214680) has net assets worth ₩76.77 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩208.66 Billion) and total liabilities (₩131.88 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩76.77 Billion |
| % of Total Assets | 36.79% |
| Annual Growth Rate | 13.04% |
| 5-Year Change | 119.87% |
| 10-Year Change | N/A |
| Growth Volatility | 20.4 |
DRTECH Corporation - Net Assets Trend (2016–2024)
This chart illustrates how DRTECH Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for DRTECH Corporation (2016–2024)
The table below shows the annual net assets of DRTECH Corporation from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩72.77 Billion | -13.97% |
| 2023-12-31 | ₩84.59 Billion | +40.11% |
| 2022-12-31 | ₩60.38 Billion | +36.86% |
| 2021-12-31 | ₩44.11 Billion | +33.28% |
| 2020-12-31 | ₩33.10 Billion | -11.41% |
| 2019-12-31 | ₩37.36 Billion | +19.25% |
| 2018-12-31 | ₩31.33 Billion | +18.20% |
| 2017-12-31 | ₩26.50 Billion | -2.91% |
| 2016-12-31 | ₩27.30 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to DRTECH Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 554.9% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ₩7.90 Billion | 10.86% |
| Other Components | ₩84.86 Billion | 116.61% |
| Total Equity | ₩72.77 Billion | 100.00% |
DRTECH Corporation Competitors by Market Cap
The table below lists competitors of DRTECH Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Able C&C
KO:078520
|
$76.87 Million |
|
Ching Feng Home Fashions Co Ltd
TW:9935
|
$76.88 Million |
|
Synchronoss Technologies Inc
NASDAQ:SNCR
|
$76.89 Million |
|
Nordic Mining ASA
OL:NOM
|
$76.90 Million |
|
ANTARES VISION SPA O.N.
F:2YK
|
$76.85 Million |
|
NorAm Drilling AS
F:TM9
|
$76.83 Million |
|
Arqit Quantum Inc.
NASDAQ:ARQQ
|
$76.81 Million |
|
Ram Ratna Wires Limited
NSE:RAMRAT
|
$76.77 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in DRTECH Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 84,568,479,560 to 72,773,225,510, a change of -11,795,254,050 (-13.9%).
- Net loss of 19,289,549,660 reduced equity.
- Dividend payments of 500,000 reduced retained earnings.
- Share repurchases of 1,321,602,050 reduced equity.
- New share issuances of 1,321,602,050 increased equity.
- Other factors increased equity by 7,494,795,610.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-19.29 Billion | -26.51% |
| Dividends Paid | ₩500.00K | -0.0% |
| Share Repurchases | ₩1.32 Billion | -1.82% |
| Share Issuances | ₩1.32 Billion | +1.82% |
| Other Changes | ₩7.49 Billion | +10.3% |
| Total Change | ₩- | -13.95% |
Book Value vs Market Value Analysis
This analysis compares DRTECH Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.95x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.82x to 1.95x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩677.92 | ₩1913.00 | x |
| 2017-12-31 | ₩641.33 | ₩1913.00 | x |
| 2018-12-31 | ₩708.62 | ₩1913.00 | x |
| 2019-12-31 | ₩762.81 | ₩1913.00 | x |
| 2020-12-31 | ₩639.17 | ₩1913.00 | x |
| 2021-12-31 | ₩779.06 | ₩1913.00 | x |
| 2022-12-31 | ₩1040.60 | ₩1913.00 | x |
| 2023-12-31 | ₩1168.24 | ₩1913.00 | x |
| 2024-12-31 | ₩983.22 | ₩1913.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently DRTECH Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -26.51%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -19.77%
- • Asset Turnover: 0.54x
- • Equity Multiplier: 2.46x
- Recent ROE (-26.51%) is below the historical average (-3.77%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -1.60% | -1.19% | 0.97x | 1.38x | ₩-3.17 Billion |
| 2017 | -6.85% | -4.68% | 0.89x | 1.64x | ₩-4.47 Billion |
| 2018 | 3.98% | 2.79% | 0.90x | 1.59x | ₩-1.89 Billion |
| 2019 | 2.53% | 1.97% | 0.67x | 1.90x | ₩-2.79 Billion |
| 2020 | -21.85% | -13.08% | 0.60x | 2.77x | ₩-10.54 Billion |
| 2021 | 9.15% | 5.75% | 0.75x | 2.13x | ₩-373.34 Million |
| 2022 | 9.89% | 6.67% | 0.74x | 2.00x | ₩-65.46 Million |
| 2023 | -2.66% | -2.43% | 0.56x | 1.94x | ₩-10.71 Billion |
| 2024 | -26.51% | -19.77% | 0.54x | 2.46x | ₩-26.57 Billion |
Industry Comparison
This section compares DRTECH Corporation's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $98,321,642,752
- Average return on equity (ROE) among peers: 7.10%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| DRTECH Corporation (214680) | ₩76.77 Billion | -1.60% | 1.72x | $76.85 Million |
| Shinhung (004080) | $87.31 Billion | 3.50% | 0.52x | $10.80 Million |
| Osang Healthcare Co.,Ltd (036220) | $199.86 Billion | 20.34% | 0.25x | $37.44 Million |
| HansBiomed Corporation (042520) | $43.16 Billion | 11.38% | 0.21x | $246.58 Million |
| JVM Co. Ltd (054950) | $98.83 Billion | 10.23% | 0.72x | $117.37 Million |
| Huvitz Co. Ltd (065510) | $51.68 Billion | 16.97% | 0.32x | $43.64 Million |
| Vieworks Co. Ltd (100120) | $188.04 Billion | 17.80% | 0.28x | $101.54 Million |
| Corentec Co Ltd (104540) | $48.30 Billion | -3.04% | 0.46x | $40.80 Million |
| Hironic Co. Ltd (149980) | $40.72 Billion | 7.13% | 0.15x | $23.71 Million |
| Laseroptek Co., Ltd. (199550) | $-3.94 Billion | 0.00% | 0.00x | $21.68 Million |
| Humasis Co. Ltd (205470) | $229.26 Billion | -13.28% | 0.45x | $48.97 Million |